Arcturus Therapeutics Holdings Inc. (ARCT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -19.44M | -16.23M | -17.15M | -5.75M | -35.14M | -284K | -23.76M | -30.14M | -5.56M | -629K | -32.41M | 50.81M |
| Operating CF Margin % | -3187.05% | -526.68% | -100% | -23.48% | -119.59% | -1.35% | -61.22% | -65.56% | -17.05% | -2.51% | -74.71% | 483% |
| Operating CF Growth % | 44.67% | -5613.73% | 27.83% | 80.91% | -532.32% | 54.85% | 26.67% | -159.33% | 84.51% | -100.39% | 23.58% | 237.98% |
| Net Income | -26.96M | -29.08M | -13.45M | -9.18M | -14.08M | -30M | -6.9M | -17.22M | -26.82M | -11.71M | -16.22M | -52.55M |
| Depreciation & Amortization | 658K | 682K | 763K | 779K | 801K | 819K | 912K | 909K | 904K | 815K | 827K | 737K |
| Stock-Based Compensation | 4.33M | 6.82M | 5.73M | 6.2M | 6.66M | 8.98M | 9.49M | 9.42M | 10.09M | 8.81M | 9.27M | 8.38M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -33K | 2.39M | -13.86M | 2.3M | 21K | -172K | 202K | 388K | 53K | 0 | 13.82M | 0 |
| Working Capital Changes | 2.57M | 2.96M | 3.67M | -5.86M | -28.55M | 20.09M | -27.47M | -23.65M | 10.21M | 1.45M | -40.1M | 94.24M |
| Change in Receivables | 4.22M | 2.47M | 9.25M | -2.63M | -10.6M | 26.23M | -6.11M | 2.97M | 5.01M | 6.16M | -35.42M | 89.68M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -142K | -1.45M | 0 | 0 | -1.01M | -2.94M | -3.77M | 4.76M | 3.87M | -12.73M | 0 | -6.2M |
| Cash from Investing | 34K | 87.34K | -181K | 0 | -137K | 0 | -80K | -328K | -240K | -875K | -981K | -354K |
| Capital Expenditures | 0 | -137.66K | -181K | 0 | -137K | 0 | -80K | -328K | -240K | -875K | -981K | -354K |
| CapEx % of Revenue | - | 4.47% | 1.06% | - | 0.47% | - | 0.21% | 0.71% | 0.74% | 3.49% | 2.26% | 3.37% |
| Acquisitions | 34K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 225K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 16K | 11.69M | 1.23M | -14.73M | 15.2M | 134K | 693K | 2.4M | 2.19M | -18.66M | 21.84M | 94K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 15M | 0 | 0 | 0 | 0 | -20M | 0 | 0 |
| Equity Issued (Net) | 16K | 12.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -733.68K | 1.23M | -14.73M | 195K | 134K | 693K | 2.4M | 2.19M | 1.34M | 21.84M | 94K |
| Net Change in Cash | -19.39M | -4.45M | -16.11M | -20.48M | -20.08M | -150K | -23.15M | -28.07M | -3.61M | -20.16M | -11.55M | 50.55M |
| Free Cash Flow | -19.44M | -16.36M | -17.33M | -5.75M | -35.27M | -284K | -23.84M | -30.47M | -5.8M | -1.5M | -33.39M | 50.45M |
| FCF Margin % | -3187.05% | -531.15% | -101.06% | -23.48% | -120.06% | -1.35% | -61.43% | -66.27% | -17.78% | -6% | -76.97% | 479.64% |
| FCF Growth % | 44.89% | -5662.2% | 27.31% | 81.11% | -508.5% | 81.12% | 28.58% | -160.39% | 84.14% | -100.96% | 25.13% | 238.44% |
| FCF per Share | -0.68 | -0.60 | -0.64 | -0.21 | -1.30 | -0.01 | -0.88 | -1.13 | -0.22 | -0.06 | -1.26 | 1.90 |
| FCF Conversion (FCF/Net Income) | 0.72x | 0.56x | 1.28x | 0.63x | 2.50x | 0.01x | 3.44x | 1.75x | 0.21x | 0.05x | 2.00x | -0.97x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |